Related Experiment Video
Updated: Jun 26, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Assessing, communicating and managing cardiovascular disease risk: a practical summary of the 2023 guideline
Garry Jennings1, Natalie Raffoul2, Mark Nelson3
1National Heart Foundation of Australia, Melbourne.
Insights
Australia
Area of Science:
- Cardiology
- Public Health
- Preventive Medicine
Background:
- The previous cardiovascular disease risk calculator overestimated risk in Australians.
- It lacked key variables like socioeconomic disadvantage, impacting heart attack and stroke incidence.
- The 2023 Australian Guideline provides the first update in over a decade.
Purpose of the Study:
- To introduce the new Australian Cardiovascular Disease Risk Calculator.
- To improve risk stratification and prediction accuracy.
- To incorporate new variables for personalized risk assessment.
Main Methods:
- The new calculator assesses 5-year risk of cardiovascular death or hospitalization.
- It categorizes risk as low (<5%), intermediate (5-10%), or high (≥10%).
- Includes reclassification factors: ethnicity, family history, mental illness, kidney disease, coronary artery calcium, and optional diabetes variables.
Main Results:
- The new calculator offers refined risk estimates.
- It allows for individualized risk assessment through specific factors.
- Clinicians should reassess patients using the new calculator if previously assessed with the outdated tool.
Conclusions:
- The 2023 Australian Cardiovascular Disease Risk Calculator represents a significant advancement in cardiovascular risk assessment.
- It provides a more accurate and personalized approach to identifying individuals at risk.
- The updated guideline and calculator aim to enhance cardiovascular disease prevention strategies in Australia.
Abstract:
The outdated cardiovascular disease risk calculator has been reported to overestimate cardiovascular disease risk for a contemporary Australian population, and does not include relevant variables, such as socioeconomic disadvantage, which has been shown to increase the incidence of both heart attack and stroke. The 2023 Australian Guideline for Assessing and Managing Cardiovascular Disease Risk marks a major milestone as the first update to Australia's cardiovascular disease prevention guideline in over a decade. The new guideline may help to refine and recategorise risk estimates, hence improving the discriminatory and predictive value of the new calculator. The new Australian Cardiovascular Disease Risk Calculator expresses risk scores as a percentage estimate of a person's probability of dying or being hospitalised due to cardiovascular disease within the next 5 years. The new calculator expresses risk scores as low (less than 5%), intermediate (5% to less than 10%), or high (10% or higher) risk over 5 years. Reclassification factors built into the new calculator are designed to help clinicians individualise risk estimates. These factors include ethnicity (e.g. First Nations status), family history of premature cardiovascular disease, severe mental illness, kidney disease and coronary artery calcium score. The new calculator also uses optional diabetes-specific variables (supporting a more granular cardiovascular disease risk assessment of people with type 2 diabetes). People who meet the clinically determined high-risk criteria (chronic kidney disease, familial hypercholesterolaemia) should not progress through the Australian Cardiovascular Disease risk calculator, but move straight to management. For a person with a cardiovascular disease risk score recorded from the outdated calculator, clinicians may want to reassess their risk using the new calculator the next time the person attends.
More Related Videos
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Pre-Procedural Guidelines for Assessing Blood Pressure
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Cardiovascular Drugs: Classification based on Therapeutic Indications
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...

